1-16 of 16
Authors: Fabiana Alves
Save search
Sort by
Journal Article

Global health initiatives and mycetoma management: the unmet promise

PDF
Ahmed Hassan Fahal and others
Transactions of The Royal Society of Tropical Medicine and Hygiene, traf001, https://doi.org/10.1093/trstmh/traf001
Published: 04 February 2025
Journal Article

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

PDF
Wan-Yu Chu and others
The Journal of Infectious Diseases, Volume 230, Issue 6, 15 December 2024, Pages e1375–e1384, https://doi.org/10.1093/infdis/jiae413
Published: 21 August 2024
Journal Article

Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment Get access

PDF
Rik Hendrickx and others
The Journal of Infectious Diseases, Volume 230, Issue 1, 15 July 2024, Pages 183–187, https://doi.org/10.1093/infdis/jiae219
Published: 28 May 2024
Journal Article
EDITOR'S CHOICE

Climate change, malaria and neglected tropical diseases: a scoping review

PDF
Petra Klepac and others
Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 118, Issue 9, September 2024, Pages 561–579, https://doi.org/10.1093/trstmh/trae026
Published: 10 May 2024
Journal Article

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia

PDF
Semra Palić and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1547–1554, https://doi.org/10.1093/jac/dkae129
Published: 10 May 2024
Journal Article

Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies

PDF
Prabin Dahal and others
Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 118, Issue 8, August 2024, Pages 481–490, https://doi.org/10.1093/trstmh/trae018
Published: 01 May 2024
Journal Article
EDITOR'S CHOICE

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis

PDF
Luka Verrest and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 11, November 2023, Pages 2702–2714, https://doi.org/10.1093/jac/dkad286
Published: 20 September 2023
Journal Article

Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial

PDF
Ahmed M Musa and others
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e1177–e1185, https://doi.org/10.1093/cid/ciac643
Published: 27 September 2022
Journal Article

AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial

PDF
Sakib Burza and others
Clinical Infectious Diseases, Volume 75, Issue 8, 15 October 2022, Pages 1423–1432, https://doi.org/10.1093/cid/ciac127
Published: 11 February 2022
Journal Article

Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study

PDF
Anke E Kip and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 5, May 2021, Pages 1258–1268, https://doi.org/10.1093/jac/dkab013
Published: 02 March 2021
Journal Article

Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa

PDF
Luka Verrest and others
Clinical Infectious Diseases, Volume 73, Issue 5, 1 September 2021, Pages 775–782, https://doi.org/10.1093/cid/ciab124
Published: 13 February 2021
Journal Article

Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa

PDF
Semra Palić and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3260–3268, https://doi.org/10.1093/jac/dkaa314
Published: 11 August 2020
Journal Article

Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial

PDF
Jane Mbui and others
Clinical Infectious Diseases, Volume 68, Issue 9, 1 May 2019, Pages 1530–1538, https://doi.org/10.1093/cid/ciy747
Published: 05 September 2018
Journal Article

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial

PDF
Ermias Diro and others
Clinical Infectious Diseases, Volume 66, Issue 3, 1 February 2018, Pages 444–451, https://doi.org/10.1093/cid/cix807
Published: 13 September 2017
Journal Article

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study

PDF
Thomas P C Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 11, November 2017, Pages 3131–3140, https://doi.org/10.1093/jac/dkx283
Published: 06 September 2017
Journal Article

Ghrelin and leptin modulate the feeding behaviour of the hawksbill turtle Eretmochelys imbricata during nesting season

PDF
Daphne Wrobel Goldberg and others
Conservation Physiology, Volume 1, Issue 1, 2013, cot016, https://doi.org/10.1093/conphys/cot016
Published: 02 July 2013